US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
WO1997033904A1
(en)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
US6455040B1
(en)
|
1997-01-14 |
2002-09-24 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
EP0857782A3
(de)
*
|
1997-01-27 |
1999-12-22 |
Smithkline Beecham Corporation |
Säugetiergen DD-1
|
US6433147B1
(en)
|
1997-01-28 |
2002-08-13 |
Human Genome Sciences, Inc. |
Death domain containing receptor-4
|
ES2284199T5
(es)
|
1997-01-28 |
2011-11-14 |
Human Genome Sciences, Inc. |
Receptor 4 que contiene dominio de muerte (dr4: receptor 4 de muerte), miembro de la superfamilia de receptores de tnf y unión a trail (apo-2l).
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US7528239B1
(en)
*
|
1997-02-13 |
2009-05-05 |
Immunex Corporation |
Receptor that binds trail
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
US20040136951A1
(en)
*
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6872568B1
(en)
|
1997-03-17 |
2005-03-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5 antibodies
|
US20050233958A1
(en)
*
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
JP4330180B2
(ja)
|
1997-03-17 |
2009-09-16 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
死ドメイン含有レセプター5
|
US20080248046A1
(en)
*
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
WO1998054202A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
DE69839401T2
(de)
|
1997-09-18 |
2009-05-07 |
Genentech Inc., San Francisco |
Dcr3 polypeptid, ein tnfr homolog
|
US20040180049A1
(en)
*
|
1998-01-26 |
2004-09-16 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
ES2368823T3
(es)
|
1998-01-26 |
2011-11-22 |
Genentech, Inc. |
Anticuerpos del receptor 4 de muerte (dr4) y usos de los mismos.
|
US20040120947A1
(en)
*
|
1998-01-26 |
2004-06-24 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
AU2007200507B2
(en)
*
|
1998-01-26 |
2010-03-11 |
Genentech, Inc. |
Antibodies to death receptor 4 (DR4) and uses thereof
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
AU4478200A
(en)
*
|
1999-04-22 |
2000-11-10 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
WO2000067793A1
(en)
*
|
1999-05-06 |
2000-11-16 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4
|
CA2374599A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Genentech, Inc. |
Dr4 antibodies and uses thereof
|
AU6928200A
(en)
*
|
1999-08-25 |
2001-03-19 |
Genome Therapeutics Corporation |
A transmembrane trap for isolating membrane bound proteins
|
EP1255558B1
(de)
|
2000-02-16 |
2006-06-14 |
Genentech, Inc. |
Anti-april antikörper und hybridomazellen
|
PL357939A1
(en)
|
2000-04-11 |
2004-08-09 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
AU2001266557A1
(en)
|
2000-04-12 |
2001-10-23 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7279160B2
(en)
|
2000-05-02 |
2007-10-09 |
The Uab Research Foundation |
Combinations of DR5 antibodies and other therapeutic agents
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
US7476383B2
(en)
*
|
2000-05-02 |
2009-01-13 |
The Uab Research Foundation |
Antibody selective for DR4 and uses thereof
|
AU2001282856A1
(en)
|
2000-06-15 |
2001-12-24 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
CA2407910C
(en)
|
2000-06-16 |
2013-03-12 |
Steven M. Ruben |
Antibodies that immunospecifically bind to blys
|
ES2317924T3
(es)
|
2000-07-27 |
2009-05-01 |
Genentech, Inc. |
Administracion secuencial de cpt-11 y polipeptido apo-2l.
|
CA2426710A1
(en)
*
|
2000-11-08 |
2002-10-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20030228309A1
(en)
*
|
2000-11-08 |
2003-12-11 |
Theodora Salcedo |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20060062786A1
(en)
*
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20020155109A1
(en)
*
|
2001-04-20 |
2002-10-24 |
Lynch David H. |
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
|
CN100475848C
(zh)
*
|
2001-05-18 |
2009-04-08 |
麒麟麦酒株式会社 |
抗trail-r抗体
|
US7361341B2
(en)
*
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20050214209A1
(en)
*
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20090226429A1
(en)
*
|
2001-05-25 |
2009-09-10 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
CA2446723C
(en)
|
2001-05-25 |
2014-01-21 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
ATE433996T1
(de)
*
|
2001-07-03 |
2009-07-15 |
Genentech Inc |
Humane dr4-antikörper und deren anwendungen
|
WO2003013584A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Genset S.A. |
Xafinix agonists and antagonists for use in the treatment of metabolic disorders
|
ES2357225T3
(es)
*
|
2001-11-01 |
2011-04-20 |
Uab Research Foundation |
Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
|
US7842668B1
(en)
|
2001-11-13 |
2010-11-30 |
Genentech, Inc. |
Apo-2 ligand/trail formulations
|
ES2351786T3
(es)
|
2001-11-13 |
2011-02-10 |
Genentech, Inc. |
Formulaciones con ligando apo2/trail y usos de las mismas.
|
US7741285B2
(en)
|
2001-11-13 |
2010-06-22 |
Genentech, Inc. |
APO-2 ligand/trail formulations
|
WO2003054216A2
(en)
*
|
2001-12-20 |
2003-07-03 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
EP2261250B1
(de)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin Fusionsproteine
|
US8658773B2
(en)
|
2011-05-02 |
2014-02-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
WO2003104395A2
(en)
*
|
2002-05-22 |
2003-12-18 |
Incyte Corporation |
Receptors and membrane-associated proteins
|
US20060141561A1
(en)
|
2002-06-24 |
2006-06-29 |
Kelley Robert F |
Apo-2 ligand/trail variants and uses thereof
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
WO2005041748A2
(en)
|
2003-09-12 |
2005-05-12 |
Minnow Medical, Llc |
Selectable eccentric remodeling and/or ablation of atherosclerotic material
|
JP2007513611A
(ja)
*
|
2003-11-26 |
2007-05-31 |
ザ クイーンズ ユニヴァーシティ オブ ベルファスト |
癌治療
|
US7892539B2
(en)
*
|
2004-03-24 |
2011-02-22 |
The Regents Of The University Of California |
Modulation of an innate immune response by altering TRIAL-R signaling
|
US20080260763A1
(en)
*
|
2004-07-01 |
2008-10-23 |
The Regents Of The University Of California |
High Throughput Proteomics
|
KR101235479B1
(ko)
*
|
2004-08-06 |
2013-02-20 |
제넨테크, 인크. |
바이오마커를 사용한 분석 및 방법
|
CN101035912A
(zh)
|
2004-08-06 |
2007-09-12 |
健泰科生物技术公司 |
使用生物标志的测定法和方法
|
NZ553171A
(en)
*
|
2004-09-08 |
2010-03-26 |
Genentech Inc |
Methods of using death receptor ligands and CD20 antibodies
|
NZ553174A
(en)
*
|
2004-09-08 |
2010-03-26 |
Genentech Inc |
Methods of using death receptor ligands Apo2L/Trail and CD20 antibodies
|
US9713730B2
(en)
|
2004-09-10 |
2017-07-25 |
Boston Scientific Scimed, Inc. |
Apparatus and method for treatment of in-stent restenosis
|
US8396548B2
(en)
|
2008-11-14 |
2013-03-12 |
Vessix Vascular, Inc. |
Selective drug delivery in a lumen
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
JP5562521B2
(ja)
|
2005-02-02 |
2014-07-30 |
ザ ユーエービー リサーチ ファンデーション |
アポトーシス誘導デスレセプターアゴニストに対する抵抗性を低減することに関する薬剤及び方法
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
US20090155247A1
(en)
*
|
2005-02-18 |
2009-06-18 |
Ashkenazi Avi J |
Methods of Using Death Receptor Agonists and EGFR Inhibitors
|
ZA200800969B
(en)
|
2005-08-16 |
2009-08-26 |
Genentech Inc |
Apoptosis sensitivity to APO2L/TRAIL by testing for GalNac-T14 expression in cells/tissues
|
AU2006283174A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell-Matrix, Inc. |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
EP3037544A1
(de)
|
2005-10-13 |
2016-06-29 |
Human Genome Sciences, Inc. |
Verfahren und zusammensetzung zur verwendung bei der behandlung von systemisch lupus erythematosus patienten mit autoantikörper-positiven leiden
|
AU2006318539B2
(en)
|
2005-11-23 |
2012-09-13 |
Genentech, Inc. |
Methods and compositions related to B cell assays
|
US8019435B2
(en)
|
2006-05-02 |
2011-09-13 |
Boston Scientific Scimed, Inc. |
Control of arterial smooth muscle tone
|
JP5479901B2
(ja)
|
2006-10-18 |
2014-04-23 |
べシックス・バスキュラー・インコーポレイテッド |
身体組織に対する所望の温度作用の誘発
|
AU2007310991B2
(en)
|
2006-10-18 |
2013-06-20 |
Boston Scientific Scimed, Inc. |
System for inducing desirable temperature effects on body tissue
|
ES2546773T3
(es)
|
2006-10-18 |
2015-09-28 |
Vessix Vascular, Inc. |
Energía de RF sintonizada y caracterización eléctrica de tejido para el tratamiento selectivo de tejidos diana
|
EP2368568A1
(de)
|
2006-11-01 |
2011-09-28 |
Immport Therapeutics, INC. |
Zusammensetzungen und Verfahren für immunodominante Antigene
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
AU2009303690B2
(en)
|
2008-09-26 |
2014-06-19 |
Tocagen Inc. |
Gene therapy vectors and cytosine deaminases
|
CN102317314A
(zh)
*
|
2008-10-10 |
2012-01-11 |
阿纳福公司 |
结合trail-r1和trail-r2的多肽
|
AU2009314133B2
(en)
|
2008-11-17 |
2015-12-10 |
Vessix Vascular, Inc. |
Selective accumulation of energy with or without knowledge of tissue topography
|
US20160095939A1
(en)
|
2014-10-07 |
2016-04-07 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
PL3903829T3
(pl)
|
2009-02-13 |
2023-08-14 |
Immunomedics, Inc. |
Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo
|
CA2774260C
(en)
|
2009-09-16 |
2018-10-09 |
Immunomedics, Inc. |
Class i anti-cea antibodies and uses thereof
|
CA2777162A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Anaphore, Inc. |
Polypeptides that bind il-23r
|
BR112012010698A2
(pt)
|
2009-11-05 |
2016-11-29 |
Uab Research Foundation |
método para tratamento de um sujeito com câncer, método de triagem de uma célula de câncer de mama, e , anticorpo
|
EP2506881B1
(de)
|
2009-12-02 |
2024-03-06 |
Immunomedics, Inc. |
Kombination aus radioimmuntherapie und antikörper-arznei-konjugaten für verbesserte krebstherapie
|
WO2011116344A2
(en)
|
2010-03-18 |
2011-09-22 |
The Uab Research Foundation |
Targeting cancer stem cells
|
CN103068330B
(zh)
|
2010-04-09 |
2016-06-29 |
Vessix血管股份有限公司 |
用于治疗组织的功率发生和控制装置
|
US9192790B2
(en)
|
2010-04-14 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Focused ultrasonic renal denervation
|
JP2013528599A
(ja)
|
2010-05-14 |
2013-07-11 |
アムジェン インコーポレイテッド |
増強デスレセプター・アゴニスト
|
US8473067B2
(en)
|
2010-06-11 |
2013-06-25 |
Boston Scientific Scimed, Inc. |
Renal denervation and stimulation employing wireless vascular energy transfer arrangement
|
US9044457B2
(en)
|
2010-06-16 |
2015-06-02 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Anti-DR4 agonist antibodies
|
US9463062B2
(en)
|
2010-07-30 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Cooled conductive balloon RF catheter for renal nerve ablation
|
US9358365B2
(en)
|
2010-07-30 |
2016-06-07 |
Boston Scientific Scimed, Inc. |
Precision electrode movement control for renal nerve ablation
|
US9155589B2
(en)
|
2010-07-30 |
2015-10-13 |
Boston Scientific Scimed, Inc. |
Sequential activation RF electrode set for renal nerve ablation
|
US9084609B2
(en)
|
2010-07-30 |
2015-07-21 |
Boston Scientific Scime, Inc. |
Spiral balloon catheter for renal nerve ablation
|
US9408661B2
(en)
|
2010-07-30 |
2016-08-09 |
Patrick A. Haverkost |
RF electrodes on multiple flexible wires for renal nerve ablation
|
EP2625263B1
(de)
|
2010-10-08 |
2020-03-11 |
Terumo BCT, Inc. |
Konfigurierbare verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem
|
US8974451B2
(en)
|
2010-10-25 |
2015-03-10 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation using conductive fluid jet and RF energy
|
US9220558B2
(en)
|
2010-10-27 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
RF renal denervation catheter with multiple independent electrodes
|
US9028485B2
(en)
|
2010-11-15 |
2015-05-12 |
Boston Scientific Scimed, Inc. |
Self-expanding cooling electrode for renal nerve ablation
|
US9089350B2
(en)
|
2010-11-16 |
2015-07-28 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
|
US9668811B2
(en)
|
2010-11-16 |
2017-06-06 |
Boston Scientific Scimed, Inc. |
Minimally invasive access for renal nerve ablation
|
US9326751B2
(en)
|
2010-11-17 |
2016-05-03 |
Boston Scientific Scimed, Inc. |
Catheter guidance of external energy for renal denervation
|
US9060761B2
(en)
|
2010-11-18 |
2015-06-23 |
Boston Scientific Scime, Inc. |
Catheter-focused magnetic field induced renal nerve ablation
|
KR101919170B1
(ko)
|
2010-11-19 |
2018-11-15 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
중화 항-ccl20 항체
|
US9192435B2
(en)
|
2010-11-22 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with cooled RF electrode
|
US9023034B2
(en)
|
2010-11-22 |
2015-05-05 |
Boston Scientific Scimed, Inc. |
Renal ablation electrode with force-activatable conduction apparatus
|
US20120157993A1
(en)
|
2010-12-15 |
2012-06-21 |
Jenson Mark L |
Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
|
US9220561B2
(en)
|
2011-01-19 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
|
WO2012117336A2
(en)
|
2011-02-28 |
2012-09-07 |
Istituto Di Ricovero E Cura A Carattere Scientifico Materno-Infantile Burlo Garofolo - Ospedale Di Alta Specializzazione E Di Rilievo Nazionale Per La Salute Della Donna E Del Bambino |
Apoptosis-inducing molecules and uses therefor
|
JP2014513128A
(ja)
|
2011-05-03 |
2014-05-29 |
ジェネンテック, インコーポレイテッド |
血管破壊剤とその使用
|
WO2013013156A2
(en)
|
2011-07-20 |
2013-01-24 |
Boston Scientific Scimed, Inc. |
Percutaneous devices and methods to visualize, target and ablate nerves
|
AU2012287189B2
(en)
|
2011-07-22 |
2016-10-06 |
Boston Scientific Scimed, Inc. |
Nerve modulation system with a nerve modulation element positionable in a helical guide
|
US9186210B2
(en)
|
2011-10-10 |
2015-11-17 |
Boston Scientific Scimed, Inc. |
Medical devices including ablation electrodes
|
US9420955B2
(en)
|
2011-10-11 |
2016-08-23 |
Boston Scientific Scimed, Inc. |
Intravascular temperature monitoring system and method
|
US10085799B2
(en)
|
2011-10-11 |
2018-10-02 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
US9364284B2
(en)
|
2011-10-12 |
2016-06-14 |
Boston Scientific Scimed, Inc. |
Method of making an off-wall spacer cage
|
US9162046B2
(en)
|
2011-10-18 |
2015-10-20 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
WO2013059202A1
(en)
|
2011-10-18 |
2013-04-25 |
Boston Scientific Scimed, Inc. |
Integrated crossing balloon catheter
|
CN104023662B
(zh)
|
2011-11-08 |
2018-02-09 |
波士顿科学西美德公司 |
孔部肾神经消融
|
WO2013074813A1
(en)
|
2011-11-15 |
2013-05-23 |
Boston Scientific Scimed, Inc. |
Device and methods for renal nerve modulation monitoring
|
US9119632B2
(en)
|
2011-11-21 |
2015-09-01 |
Boston Scientific Scimed, Inc. |
Deflectable renal nerve ablation catheter
|
US9265969B2
(en)
|
2011-12-21 |
2016-02-23 |
Cardiac Pacemakers, Inc. |
Methods for modulating cell function
|
WO2013096913A2
(en)
|
2011-12-23 |
2013-06-27 |
Vessix Vascular, Inc. |
Methods and apparatuses for remodeling tissue of or adjacent to a body passage
|
EP2797534A1
(de)
|
2011-12-28 |
2014-11-05 |
Boston Scientific Scimed, Inc. |
Vorrichtung und verfahren zur nervenmodulation unter verwendung eines neuartigen ablationskatheters mit polymerischen ablationselementen
|
US9050106B2
(en)
|
2011-12-29 |
2015-06-09 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
EP2831116A1
(de)
|
2012-03-28 |
2015-02-04 |
Amgen Inc. |
Dr5-rezeptoragonistkombinationen
|
US10660703B2
(en)
|
2012-05-08 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices
|
EP2684896A1
(de)
|
2012-07-09 |
2014-01-15 |
International-Drug-Development-Biotech |
Antikörper gegen die DR5-Familie, bispezifische oder multivalente Antikörper gegen die DR5-Familie und Verfahren zu deren Verwendung
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
US10321946B2
(en)
|
2012-08-24 |
2019-06-18 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices with weeping RF ablation balloons
|
EP2895095A2
(de)
|
2012-09-17 |
2015-07-22 |
Boston Scientific Scimed, Inc. |
Selbstpositionierendes elektrodensystem und verfahren für renale nervenmodulation
|
US10549127B2
(en)
|
2012-09-21 |
2020-02-04 |
Boston Scientific Scimed, Inc. |
Self-cooling ultrasound ablation catheter
|
WO2014047411A1
(en)
|
2012-09-21 |
2014-03-27 |
Boston Scientific Scimed, Inc. |
System for nerve modulation and innocuous thermal gradient nerve block
|
WO2014059165A2
(en)
|
2012-10-10 |
2014-04-17 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices and methods
|
EP2909324B1
(de)
|
2012-10-25 |
2020-02-26 |
Tocagen Inc. |
Retroviraler vektor mit mini-promoter-kassette
|
BR112015013444B1
(pt)
|
2012-12-13 |
2022-11-01 |
Immunomedics, Inc |
Uso de um imunoconjugado
|
US9956033B2
(en)
|
2013-03-11 |
2018-05-01 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
WO2014143571A1
(en)
|
2013-03-11 |
2014-09-18 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9808311B2
(en)
|
2013-03-13 |
2017-11-07 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
SI2970473T1
(sl)
|
2013-03-14 |
2017-10-30 |
Bristol-Myers Squibb Company |
Kombinacija dr5 agonista in anti-pd-1 antagonista in postopek uporabe
|
JP6139772B2
(ja)
|
2013-03-15 |
2017-05-31 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
電極パッドと共に使用するための制御ユニットおよび漏電を推定するための方法
|
US10265122B2
(en)
|
2013-03-15 |
2019-04-23 |
Boston Scientific Scimed, Inc. |
Nerve ablation devices and related methods of use
|
CN105473090B
(zh)
|
2013-03-15 |
2019-05-03 |
波士顿科学国际有限公司 |
重建身体通道的组织或邻近身体通道的组织的方法及装置
|
JP2016523147A
(ja)
|
2013-06-21 |
2016-08-08 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
同乗型電極支持体を備えた腎除神経バルーンカテーテル
|
CN105473092B
(zh)
|
2013-06-21 |
2019-05-17 |
波士顿科学国际有限公司 |
具有可旋转轴的用于肾神经消融的医疗器械
|
US9707036B2
(en)
|
2013-06-25 |
2017-07-18 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation using localized indifferent electrodes
|
AU2014284558B2
(en)
|
2013-07-01 |
2017-08-17 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
US10660698B2
(en)
|
2013-07-11 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation
|
CN105377170A
(zh)
|
2013-07-11 |
2016-03-02 |
波士顿科学国际有限公司 |
具有可伸展电极组件的医疗装置
|
EP3049007B1
(de)
|
2013-07-19 |
2019-06-12 |
Boston Scientific Scimed, Inc. |
Nierendenervierungsballon mit spiralförmiger bipolarer elektrode
|
CN105392435B
(zh)
|
2013-07-22 |
2018-11-09 |
波士顿科学国际有限公司 |
具有扭绞球囊的肾神经消融导管
|
WO2015013205A1
(en)
|
2013-07-22 |
2015-01-29 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
WO2015027096A1
(en)
|
2013-08-22 |
2015-02-26 |
Boston Scientific Scimed, Inc. |
Flexible circuit having improved adhesion to a renal nerve modulation balloon
|
EP3041425B1
(de)
|
2013-09-04 |
2022-04-13 |
Boston Scientific Scimed, Inc. |
Hochfrequenz (hf)-ballonkatheter mit spülungs- und kühlfunktion
|
CN105530885B
(zh)
|
2013-09-13 |
2020-09-22 |
波士顿科学国际有限公司 |
具有气相沉积覆盖层的消融球囊
|
CN105592778B
(zh)
|
2013-10-14 |
2019-07-23 |
波士顿科学医学有限公司 |
高分辨率心脏标测电极阵列导管
|
US11246654B2
(en)
|
2013-10-14 |
2022-02-15 |
Boston Scientific Scimed, Inc. |
Flexible renal nerve ablation devices and related methods of use and manufacture
|
US9770606B2
(en)
|
2013-10-15 |
2017-09-26 |
Boston Scientific Scimed, Inc. |
Ultrasound ablation catheter with cooling infusion and centering basket
|
AU2014334574B2
(en)
|
2013-10-15 |
2017-07-06 |
Boston Scientific Scimed, Inc. |
Medical device balloon
|
US10945786B2
(en)
|
2013-10-18 |
2021-03-16 |
Boston Scientific Scimed, Inc. |
Balloon catheters with flexible conducting wires and related methods of use and manufacture
|
US10271898B2
(en)
|
2013-10-25 |
2019-04-30 |
Boston Scientific Scimed, Inc. |
Embedded thermocouple in denervation flex circuit
|
JP6633522B2
(ja)
|
2013-11-16 |
2020-01-22 |
テルモ ビーシーティー、インコーポレーテッド |
バイオリアクターにおける細胞増殖
|
EP3091922B1
(de)
|
2014-01-06 |
2018-10-17 |
Boston Scientific Scimed, Inc. |
Reissfeste flexible schaltungsanordnung
|
EP3095460A4
(de)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chirales nukleinsäureadjuvans mit antiallergischer wirkung und antiallergikum
|
US11000679B2
(en)
|
2014-02-04 |
2021-05-11 |
Boston Scientific Scimed, Inc. |
Balloon protection and rewrapping devices and related methods of use
|
WO2015119890A1
(en)
|
2014-02-04 |
2015-08-13 |
Boston Scientific Scimed, Inc. |
Alternative placement of thermal sensors on bipolar electrode
|
AU2015219495B2
(en)
|
2014-02-21 |
2019-11-21 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to Trop-2 expressing cells
|
EP3110445A4
(de)
|
2014-02-25 |
2017-09-27 |
Immunomedics, Inc. |
Humanisierter rfb4-anti-cd22-antikörper
|
US11299528B2
(en)
|
2014-03-11 |
2022-04-12 |
D&D Pharmatech Inc. |
Long acting TRAIL receptor agonists for treatment of autoimmune diseases
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
US9580495B2
(en)
|
2014-06-24 |
2017-02-28 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
JP6830059B2
(ja)
|
2014-09-26 |
2021-02-17 |
テルモ ビーシーティー、インコーポレーテッド |
スケジュール化された細胞フィーディング
|
JP6746845B2
(ja)
|
2015-04-22 |
2020-08-26 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け
|
EP3313443B9
(de)
|
2015-06-25 |
2023-10-04 |
Immunomedics, Inc. |
Kombination von anti-hla-dr- oder anti-trop-2-antikörpern mit mikrotubuli-inhibitoren, parp-inhibitoren, bruton-kinase-inhibitoren oder phosphoinositol-3-kinase-inhibitoren zur signifikanten verbesserung des therapeutischen ergebnisses bei krebs
|
EP3316885B1
(de)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antikörper-sn-38-immunkonjugate mit einem cl2a-linker
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
CA3007033A1
(en)
|
2015-12-01 |
2017-06-08 |
Genmab B.V. |
Anti-dr5 antibodies and methods of use thereof
|
CA3008392C
(en)
|
2015-12-17 |
2021-11-09 |
The Johns Hopkins University |
Ameliorating systemic sclerosis with death receptor agonists
|
JP7281795B2
(ja)
|
2016-04-07 |
2023-05-26 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
膵炎および疼痛をデス受容体アゴニストで処置するための組成物および方法
|
EP3464565A4
(de)
|
2016-05-25 |
2020-01-01 |
Terumo BCT, Inc. |
Zellexpansion
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
CN106243215B
(zh)
*
|
2016-08-17 |
2019-09-03 |
哈尔滨医科大学 |
一种人trail i型受体激动性抗原表位多肽及其抗体和应用
|
EP3323428A1
(de)
|
2016-11-17 |
2018-05-23 |
CNRS Centre National de la Recherche Scientifique |
Selektive c-flip-hemmer als antikrebsmittel
|
CN117247899A
(zh)
|
2017-03-31 |
2023-12-19 |
泰尔茂比司特公司 |
细胞扩增
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
EP3910331A1
(de)
|
2020-05-15 |
2021-11-17 |
iOmx Therapeutics AG |
Intrazelluläre kinase in verbindung mit resistenz gegen t-zell-vermittelte zytotoxizität und verwendungen davon
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
WO2022239720A1
(ja)
|
2021-05-10 |
2022-11-17 |
公益財団法人川崎市産業振興財団 |
抗原への結合親和性を低減させた抗体
|
EP4257132A1
(de)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Sik3-inhibitoren zum behandeln von krankheiten, die gegen death-rezeptor -signaltransduktion resistent sind
|